Effects of Lurasidone on Left Ventricle Systolic Functions
Launched by AYDIN ADNAN MENDERES UNIVERSITY · Nov 17, 2024
Trial Information
Current as of July 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a medication called lurasidone, which is commonly used to treat schizophrenia and bipolar disorder. The main goal is to find out if lurasidone has any harmful effects on the heart, specifically how well the heart's left ventricle (the main pumping chamber) works. Researchers want to ensure that this medication is safe for patients who need it, without causing damage to their heart.
To participate in this study, individuals need to be between 18 and 65 years old and have been diagnosed with either schizophrenia or bipolar disorder. They should also be planning to use lurasidone and not have any serious heart conditions like coronary artery disease or heart failure. Participants will be monitored throughout the study to check their heart function while using lurasidone. It's important to note that the trial is not yet recruiting participants, so those interested will need to wait until it officially begins.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 18 to 65 years
- • Diagnosed with schizophrenia or bipolar disorder by the psychiatry clinic of our center and indicated to use lurasidone molecule
- • Hasn't been diagnosed with coronary artery disease, any kind of heart failure or severe valvular disease
- Exclusion Criteria:
- • Patients who do not agree to participate to the trial
- • Patient who do not meet the inclusion criteria
About Aydin Adnan Menderes University
Aydin Adnan Menderes University is a leading academic institution based in Turkey, renowned for its commitment to advancing medical research and education. The university actively sponsors clinical trials that aim to explore innovative therapeutic approaches and enhance patient care. With a multidisciplinary team of experts, state-of-the-art facilities, and a dedication to ethical research practices, Aydin Adnan Menderes University fosters a collaborative environment that supports the development of groundbreaking medical solutions, ultimately aiming to improve health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aydin, Zafer, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported